Alector to Participate at the Cowen 42nd Annual Health Care Conference
02 March 2022 - 8:05AM
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology
company pioneering the discovery and development of
immuno-neurology therapeutics, today announced management will
participate in a panel discussion at the Cowen Annual Health
Care Conference on Tuesday, March 8, 2022, at 2:10
p.m. ET.
A live webcast of the panel will be available on the “Events
& Presentations” page within the Investors section of the
Alector website at http://investors.alector.com. A replay will
be available on the Alector website for 30 days following the
event.
About AlectorAlector is a clinical-stage
biotechnology company pioneering immuno-neurology, a novel
therapeutic approach for the treatment of neurodegenerative
diseases. Immuno-neurology targets immune dysfunction as a
root cause of multiple pathologies that are drivers of degenerative
brain disorders. Alector has discovered and is developing a broad
portfolio of innate immune system programs, designed to
functionally repair genetic mutations that cause dysfunction of the
brain’s immune system and enable the rejuvenated immune cells to
counteract emerging brain pathologies. Alector’s immuno-neurology
product candidates are supported by biomarkers and target
genetically defined patient populations in frontotemporal dementia
and Alzheimer’s disease. This scientific approach is also the basis
for the company’s immuno-oncology programs. Alector is
headquartered in South San Francisco, California. For
additional information, please
visit www.alector.com.
Contacts:
1AB (media)Dan Budwick973-271-6085dan@1abmedia.com
Argot Partners (investors)Eric Kasper/Carrie McKimArgot
Partners212.600.1902alector@argotpartners.com
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Apr 2023 to Apr 2024